A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-18
SponsorKsana Health

About this trial

Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death among youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to provide a unique understanding of risk factors, including psychological distress, anhedonia and behavioral withdrawal, and sleep disturbance among high-risk individuals. This project aims to enhance the effectiveness of the delivery of preventative health care to youth at risk for suicide by developing a comprehensive digital platform that allows practitioners to integrate mobile sensing data and HIPAA-compliant client communication tools into their management of these young people.

Eligibility criteria

Qualifiers

Written informed assent from adolescents ages 13-17 years old and permission from legal guardians, or consent from adolescents age 18 years old.

Receiving treatment at the Intensive Adolescent and Family DBT Pgogram

13-18 years old

Owns a personal smartphone (Android or iPhone 7+)

Disqualifiers

Adolescents who require a higher level of care (i.e., are not admitted to the Intensive Outpatient DBT program)

Adolescents who are receiving treatment at the Intensive Adolescent and Family DBT program and have already been assigned a clinician

Trial design

Treatments tested in this trial

  • Vira
  • Treatment as Usual (TAU)

Treatment groups

78 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ksana Health

Lead sponsor

Columbia University

Collaborator

National Institute of Mental Health (NIMH)

Collaborator